Mersana CEO details path forward after breakup with Takeda
January 10, 2019 at 06:52 AM EST
Mersana executives discussed data from its ovarian and lung cancer drug trial Wednesday. The biotech also plans to disclose its next clinical candidate in the second half of 2019.
